Natacha Driessens
Université libre de Bruxelles
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Natacha Driessens.
Endocrine-related Cancer | 2009
Natacha Driessens; Soetkin Versteyhe; Chiraz Ghaddhab; Agnès Burniat; Xavier De Deken; Jacqueline Van Sande; Jacques Emile Dumont; Françoise Miot; Bernard Corvilain
DNA double-strand breaks (DSBs) are considered as one of the primary causes of cancer but their induction by hydrogen peroxide (H(2)O(2)) is still controversial. In this work, we studied whether the high levels of H(2)O(2) produced in the thyroid to oxidize iodide could induce DNA modifications. Scores of DNA damage, in terms of strand breaks, were obtained by comet assay (alkaline condition for single-strand breaks (SSBs) and neutral condition for DSBs). We demonstrated that in a rat thyroid cell line (PCCl3), non-lethal concentrations of H(2)O(2) (0.1-0.5 mmol/l) as well as irradiation (1-10 Gy) provoked a large number of SSBs ( approximately 2-3 times control DNA damage values) but also high levels of DSBs (1.2-2.3 times control DNA damage values). We confirmed the generation of DSBs in this cell line and also in human thyroid in primary culture and in pig thyroid slices by measuring phosphorylation of histone H2AX. L-Buthionine-sulfoximine, an agent that depletes cells of glutathione, decreased the threshold to observe H(2)O(2)-induced DNA damage. Moreover, we showed that DNA breaks induced by H(2)O(2) were more slowly repaired than those induced by irradiation. In conclusion, H(2)O(2) causes SSBs and DSBs in thyroid cells. DSBs are produced in amounts comparable with those observed after irradiation but with a slower repair. These data support the hypothesis that the generation of H(2)O(2) in thyroid could also play a role in mutagenesis particularly in the case of antioxidant defense deficiency.
Endocrinology | 2008
Agnès Burniat; Ling Jin; Vincent Detours; Natacha Driessens; Jean-Christophe Goffard; Massimo Santoro; Jay L. Rothstein; Jacques Emile Dumont; Françoise Miot; Bernard Corvilain
We studied gene expression profiles in two mouse models of human thyroid carcinoma: the Tg-RET/PTC3 (RP3) and Tg-E7 mice. RP3 fusion gene is the most frequent mutation found in the first wave post-Chernobyl papillary thyroid cancers (PTCs). E7 is an oncoprotein derived from the human papillomavirus 16 responsible for most cervical carcinoma in women. Both transgenic mice develop thyroid hyperplasia followed by solid differentiated carcinoma in older animals. To understand the different steps leading to carcinoma, we analyzed thyroid gene expression in both strains at different ages by microarray technology. Important biological processes were differentially regulated in the two tumor types. In E7 thyroids, cell cycle was the most up-regulated process, an observation consistent with the huge size of these tumors. In RP3 thyroids, contrary to E7 tumors, several human PTC characteristics were observed: overexpression of many immune-related genes, regulation of human PTC markers, up-regulation of EGF-like growth factors and significant regulation of angiogenesis and extracellular matrix remodeling-related genes. However, similarities were incomplete; they did not concern the overall gene expression and were not conserved in old animals. Therefore, RP3 tumors are partial and transient models of human PTC. They constitute a good model, especially in young animals, to study the respective role of the biological processes shared with human PTC and will allow testing drugs targeting these validated variables.
The Journal of Clinical Endocrinology and Metabolism | 2013
Soetkin Versteyhe; Natacha Driessens; Chiraz Ghaddhab; Maxime Tarabichi; Candice Hoste; Jacques Emile Dumont; Françoise Miot; Bernard Corvilain; Vincent Detours
CONTEXT Radiation is an established cause of thyroid cancer, and growing evidence supports a role for hydrogen peroxide (H2O2) in spontaneous thyroid carcinogenesis. Little is known about the molecular programs activated by these agents in thyrocytes. OBJECTIVE The purpose of this study was to compare the responses of thyrocytes and T cells to H2O2 and radiation. METHODS We profiled the DNA damage and cell death induced by γ-radiation (0.1-5 Gy) and H2O2 (0.0025-0.3 mM) in primary human thyrocytes and T cells. We next prepared thyroid and T-cell primary cultures from 8 donors operated for noncancerous thyroid pathological conditions and profiled their genome-wide transcriptional response 4 hours after (1) exposure to 1-Gy radiation, (2) treatment with H2O2 and (3) no treatment. Two H2O2 concentrations were investigated, calibrated in each cell type to elicit levels of single- and double-strand breaks equivalent to 1-Gy γ-radiation. RESULTS Although thyrocytes and T cells had comparable radiation responses, 3- to 10-fold more H2O2 was needed to induce detectable DNA damage in thyrocytes. At H2O2 and radiation doses inducing double-strand breaks, cell death occurred after 24 hours in T cells but not in thyrocytes. The transcriptional responses of thyrocytes and T cells to radiation were similar, involving DNA repair and cell death genes. In addition to this transcriptional program, H2O2 also up-regulated antioxidant genes in thyrocytes, including glutathione peroxidases and heme oxygenase at the double-strand breaks-inducing concentration. In contrast, a transcriptional storm involving thousands of genes was raised in T cells. Finally, we showed that inhibiting glutathione peroxidases activity increased the DNA damaging effect of H2O2 in thyrocytes. CONCLUSION We propose that high H2O2 production in thyrocytes is matched with specific transcriptionally regulated antioxidant protection.
Journal of the Endocrine Society | 2018
Aglaia Kyrilli; Maria Lytrivi; Marie Sylvie Bouquegneau; Pieter Demetter; Valerio Lucidi; Camilo Garcia; Rodrigo Moreno-Reyes; Antoine Tabarin; Bernard Corvilain; Natacha Driessens
Primary pigmented nodular adrenal disease (PPNAD) accounts for <1% of ACTH-independent Cushing syndrome. We describe the case of twin female patients with PPNAD who both had sustainable disease control after unilateral adrenalectomy, which corroborates current evidence in favor of unilateral adrenalectomy for a subset of patients with PPNAD. Patient A presented with a 10-kg weight gain over the past year and facial plethora. Diagnostic evaluation revealed abolition of normal cortisol rhythm with suppressed ACTH levels, normal adrenal CT and MRI imaging and a slightly left-predominant adrenal uptake on 131I iodomethyl norcholesterol scintigraphy coupled with single-photon emission CT/CT. PPNAD was confirmed after genetic testing revealed a known pathogenic PRKA1A mutation (c.709 (-7-2) del6). At that time, her twin sister (patient B) was asymptomatic. Patient A underwent successful unilateral adrenalectomy and histology confirmed PPNAD. Two years after initial onset of symptoms in patient A, patient B was seen for the same subtle symptoms of progressive weight gain. Diagnostic test results were identical, revealing the same clinical features and mutational status as patient A. Patient B also underwent unilateral adrenalectomy with a favorable outcome. Follow-up 3 years after surgery for patient A and 18 months for patient B showed sustained disease control without recurrence and uncompromised quality of life, with no adrenal insufficiency having occurred. Unilateral adrenalectomy can be a successful therapeutic approach for patients with PPNAD with a mild phenotype without the risk and the inconvenience of subsequent adrenal insufficiency, which alters quality of life.
The Journal of Clinical Endocrinology and Metabolism | 2007
Yue Song; Natacha Driessens; Mj Costa; X. De Deken; Vincent Detours; Bernard Corvilain; Carine Maenhaut; Françoise Miot; J. Van Sande; Marie-Christine Many; Jacques Emile Dumont
17th European Congress of Endocrinology | 2015
Maria Lytrivi; Denis Brisbois; Bernard Corvilain; Pieter Demetter; Camilo Garcia; Valerio Lucidi; Rodrigo Moreno-Reyes; Stella Vudu; C. Duparc; Julien Wils; H. Lefebvre; Estelle Louiset; Natacha Driessens
Annales D Endocrinologie | 2018
Tiphaine Carton; Elise Mathieu; Fleur Wolff; Bernard Corvilain; Natacha Driessens
Annales D Endocrinologie | 2017
Anne-Sophie Azzi; Natacha Driessens; Agnès Linglart; Bernard Corvilain; Cécile Brachet; Claudine Heinrichs; Erika Boros
Annales D Endocrinologie | 2017
E. Jelloul; Valerio Lucidi; Pieter Demetter; Bernard Corvilain; Natacha Driessens
Annales D Endocrinologie | 2016
Z. Haouchine; A. Vujovic; J. Desir; Bernard Corvilain; Natacha Driessens